Liver Diseases  >>  Inrebic (fedratinib)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Inrebic (fedratinib) / BMS
NCT01762462: Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic Impairment

Completed
1
17
US
SAR302503
Sanofi
Hepatic Impairment
03/13
03/13

Download Options